Follow
Nick Cox
Nick Cox
Senior Director of Chemical Biology, Novo Nordisk
Verified email at novonordisk.com
Title
Cited by
Cited by
Year
Integrin‐Targeting Knottin Peptide–Drug Conjugates Are Potent Inhibitors of Tumor Cell Proliferation
N Cox, JR Kintzing, M Smith, GA Grant, JR Cochran
Angewandte Chemie International Edition 55 (34), 9894-9897, 2016
842016
Copper‐Catalyzed Reduction of Alkyl Triflates and Iodides: An Efficient Method for the Deoxygenation of Primary and Secondary Alcohols
H Dang, N Cox, G Lalic
Angewandte Chemie International Edition 53 (3), 752-756, 2014
642014
NHC–copper hydrides as chemoselective reducing agents: catalytic reduction of alkynes, alkyl triflates, and alkyl halides
N Cox, H Dang, AM Whittaker, G Lalic
Tetrahedron 70 (27-28), 4219-4231, 2014
472014
Catalytic Asymmetric Synthesis of Cyclic Ethers Containing an α‐Tetrasubstituted Stereocenter
N Cox, MR Uehling, KT Haelsig, G Lalic
Angewandte Chemie International Edition 18 (52), 4878-4882, 2013
452013
Niclosamide suppresses acute myeloid leukemia cell proliferation through inhibition of CREB-dependent signaling pathways
HD Chae, N Cox, GV Dahl, NJ Lacayo, KL Davis, S Capolicchio, M Smith, ...
Oncotarget 9 (4), 4301, 2018
262018
Tethered NHC ligands for stereoselective alkyne semihydrogenations
F Pape, JF Teichert
Synthesis 49 (11), 2470-2482, 2017
252017
An inter-laboratory retrospective analysis of immunotoxicological endpoints in non-human primates: Flow cytometry immunophenotyping
CM Krejsa, MB Neradilek, NL Polissar, N Cox, D Clark, L Cowan, ...
Journal of Immunotoxicology 10 (4), 361-372, 2013
122013
Evaluation of VGF peptides as potential anti-obesity candidates in pre-clinical animal models
LS Dalbøge, JM Jacobsen, S Mehrotra, AJ Mercer, N Cox, F Liu, ...
Peptides 136, 170444, 2021
102021
SAR optimization studies on modified salicylamides as a potential treatment for acute myeloid leukemia through inhibition of the CREB pathway
HD Chae, N Cox, S Capolicchio, JW Lee, N Horikoshi, S Kam, AA Ng, ...
Bioorganic & Medicinal Chemistry Letters 29 (16), 2307-2315, 2019
102019
Small molecule screen for inhibitors of expression from canonical CREB response element-containing promoters
B Mitton, K Hsu, R Dutta, BC Tiu, N Cox, KG McLure, HD Chae, M Smith, ...
Oncotarget 7 (8), 8653, 2016
72016
Copper-catalyzed semi-reduction of alkynes
N Cox, H Dang, AM Whittaker, G Lalic
Org. Synth 93, 385-398, 2016
72016
Minutes: Board of Directors
J Mann, SI Director, A Odell, E Director, M Smith, N Cox, MMSE Director, ...
32020
An investigational in vivo base editing medicine targeting ANGPTL3, VERVE-201, achieves potent and LDLR-independent liver editing in mouse models
R Lee, J Denizio, T Mizoguchi, C Dutta, V Clendaniel, R Garrity, N Cox, ...
European Heart Journal 44 (Supplement_2), ehad655. 2521, 2023
12023
The Salicylamide Derivative, Niclosamide, Inhibits CREB Function in Acute Myeloid Leukemia Cells In Vitro and In Vivo
HD Chae, N Cox, X Zhang, JW Lee, D Morgens, MC Bassik, M Smith, ...
Blood 128 (22), 1647, 2016
2016
Innentitelbild: Integrin-Targeting Knottin Peptide-Drug Conjugates Are Potent Inhibitors of Tumor Cell Proliferation (Angew. Chem. 34/2016).
N Cox, JR Kintzing, M Smith, GA Grant, JR Cochran
Angewandte Chemie 128 (34), 2016
2016
Inside Cover: Integrin‐Targeting Knottin Peptide–Drug Conjugates Are Potent Inhibitors of Tumor Cell Proliferation (Angew. Chem. Int. Ed. 34/2016)
N Cox, JR Kintzing, M Smith, GA Grant, JR Cochran
Angewandte Chemie International Edition 55 (34), 9796-9796, 2016
2016
Engineered knottin peptide-drug conjugates selectively deliver small molecules to brain tumors in mice
N Cox, J Kintzing, N Currier, S Ackerman, S DePorter, M Smith, G Grant, ...
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 251, 2016
2016
Development of Practical Synthetic Tools Using Copper and Gold Catalysis
N Cox
2014
The system can't perform the operation now. Try again later.
Articles 1–18